- Previous Close
0.0750 - Open
0.0550 - Bid 0.0550 x --
- Ask 0.0760 x --
- Day's Range
0.0550 - 0.0750 - 52 Week Range
0.0300 - 0.0750 - Volume
600 - Avg. Volume
770 - Market Cap (intraday)
9.9M - Beta (5Y Monthly) --
- PE Ratio (TTM)
7.50 - EPS (TTM)
0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Pasture Holdings Ltd. operates as a pharmaceutical products and medical supply company in Japan, Hong Kong, Canada, Singapore, and internationally. The company operates through three segments: Pharmaceutical Wholesale and Drop-Shipment; Masks and Medical Supplies; and Other Services. It is involved in the wholesale procurement and transshipment of pharmaceutical and nutraceutical products, such as vaccines and oncology treatments; and backend support of pharmaceutical supplies to international clients' online pharmacy businesses. The company also sells surgical masks, n95 respirators, surgical n95 respirators, and n95 respirators; wound care products; urology and drainage; personal protective equipment; and IV therapy and vascular access. In addition, it offers oral disintegrating strips; and pet pharmaceutical and nutraceutical products and services; and furlife, a mobile application for pets. The company was founded in 1996 and is based in Singapore. Pasture Holdings Ltd. is a subsidiary of PMI Holdings Pte. Ltd.
pasturegroup.comRecent News: UUK.SI
View MorePerformance Overview: UUK.SI
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UUK.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UUK.SI
View MoreValuation Measures
Market Cap
9.90M
Enterprise Value
5.13M
Trailing P/E
6.31
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.48
Price/Book (mrq)
1.54
Enterprise Value/Revenue
0.25
Enterprise Value/EBITDA
2.20
Financial Highlights
Profitability and Income Statement
Profit Margin
7.64%
Return on Assets (ttm)
7.14%
Return on Equity (ttm)
27.78%
Revenue (ttm)
15.51M
Net Income Avi to Common (ttm)
1.19M
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
5.27M
Total Debt/Equity (mrq)
38.62%
Levered Free Cash Flow (ttm)
-22k